Table 1 Incidence proportion and median survival in patients with metastases at diagnosis
Metastases subtype | Incidence Proportion of all-cause mortality cohort, % | Median survival (IQR), month | Incidence Proportion of cancer-specific mortality cohort, % | Median survival (IQR), month |
|---|---|---|---|---|
Bone | 0.9 | 5.0 (1.0–11.0) | 1.6 | 4.0 (1.0–9.0) |
Liver | 6.7 | 9.0 (2.0–25.0) | 9.9 | 6.0 (1.0–19.0) |
Lung | 5.8 | 9.0 (2.0–24.0) | 8.8 | 6.0 (1.0–21.0) |
Brain | 0.2 | 3.5 (1.0–11.0) | 0.3 | 3.0 (1.0–7.0) |
Lymph | 0.9 | 4.0 (1.0–7.0) | 0.5 | 1.5 (1.0–5.75) |
Bone only | 0.4 | 7.0 (2.0–19.5) | 0.6 | 6.0 (2.0–14.5) |
Liver only | 0.1 | 10.0 (2.0–28.0) | 6.9 | 7.0 (1.0–20.0) |
Lung only | 3.9 | 11.0 (2.0–25.0) | 5.8 | 8.0 (1.0–22.0) |
Lymph only | 0.5 | 5.0 (2.0–8.0) | 0.2 | 2.0 (1.0–4.5) |
Brain only | 4.8 | 4.0 (2.0–12.0) | 0.2 | 2.5 (2.0–7.75) |